| Authors: |
Malik UI; Department of Cardiology, The Permanente Medical Group, San Francisco, California., Ambrosy AP; Department of Cardiology, The Permanente Medical Group, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California., Ku IA; Department of Cardiology, The Permanente Medical Group, San Francisco, California., Mishell JM; Department of Cardiology, The Permanente Medical Group, San Francisco, California., Kar S; Los Robles Regional Medical Center, Thousand Oaks, California; Bakersfield Heart Hospital, Bakersfield, California., Lim DS; Division of Cardiology, University of Virginia, Charlottesville, Virginia., Whisenant BK; Intermountain Medical Center Heart Institute, Salt Lake City, Utah., Cohen DJ; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri., Arnold SV; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri; Saint Luke's Mid America Heart Institute, Kansas City, Missouri., Kotinkaduwa LN; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York., Lindenfeld J; Vanderbilt Heart and Vascular Institute, Nashville, Tennessee., Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio., Mack MJ; Baylor Scott & White Health, Plano, Texas., Stone GW; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: gregg.stone@mountsinai.org. |
